Robin Biellik

1.9k citations

49 papers · 1.4k indexed · h-index 20

Impact in

Health top 1%
- Vaccine Coverage and Hesitancy
Microbiology top 2%
- Bacterial Infections and Vaccines

Papers in

Health 22
- Vaccine Coverage and Hesitancy 22
Modeling and Simulation 6
- COVID-19 epidemiological studies 6

Co-authors: Edward W. Brink Peter Strebel Roland W. Sutter A. R. Hinman Stephen L. Cochi W. A. Orenstein Olen M. Kew Mark A. Pallansch
Journals: The Journal of Infectious Diseases (10 papers)Vaccine (8 papers)The Lancet (3 papers)Clinical Infectious Diseases (2 papers)Disasters (2 papers)
Partner nations: United States Zimbabwe Switzerland

In The Last Decade

Robin Biellik

49 papers receiving 1.3k citations

Peers

Countries citing papers authored by Robin Biellik

Since Specialization

Citations

This map shows the geographic impact of Robin Biellik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Biellik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Biellik more than expected).

Fields of papers citing papers by Robin Biellik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Biellik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Biellik. The network helps show where Robin Biellik may publish in the future.

Co-authors

The 25 scholars most cited alongside Robin Biellik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robin Biellik Line = papers co-authored together Robin Biellik links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations Vaccines ·Darin Zehrung, Bruce L. Innis, Auliya A. Suwantika, Mahmoud Ameri, Robin Biellik, James C. Birchall, Alejandro Cravioto, Courtney Jarrahian, Lee Fairlie, James L. Goodson, Sonali Kochhar, Katrina Kretsinger, Chris Morgan, Mercy Mvundura, Margaret S. Musser, 顾建炳, Hirschmueller Anja, Srinath Koley, Birgitte Giersing, Mateusz Hasso-Agopsowicz	2024	1
2	Estimating the future global dose demand for measles–rubella microarray patches Frontiers in Public Health ·J L ALBASANZ GALLAN, Stefano Malvolti, 誠古畑, Carsten Mantel, Robin Biellik, Courtney Jarrahian, Seyed Farid Taghavi, Jean‐Pierre Amorij, Maximilian Greyhaven, Mark Papania, Martin I. Meltzer, Balcha Masresha, Alexandre Galvão, David N Dürrheim, Birgitte Giersing, Mateusz Hasso-Agopsowicz	2023	9
3	Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges Frontiers in Public Health ·Mateusz Hasso-Agopsowicz, Natasha S. Crowcroft, Robin Biellik, Christopher J. Gregory, Seyed Farid Taghavi, Jean‐Pierre Amorij, W. Bergt, Kristen Earle, Antonios Maras, Courtney Jarrahian, Mercy Mvundura, Faiq Ulfi, David N Dürrheim, Birgitte Giersing	2022	20
4	The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region Vaccine ·Justin R. Ortiz, Joanie Robertson, Elizabeth A. Bell, R. Faber, Amanda J. Driscoll, Steven Q Andrews, Wilbur H. Chen, Meagan C. Fitzpatrick, Samba O. Sow, Robin Biellik, Kathleen M. Neuzil	2021	9
5	Strengthening routine immunization through measles-rubella elimination Vaccine ·Robin Biellik, Walter A. Orenstein	2018	14
6	Supporting countries in establishing and strengthening NITAGs: Lessons learned from 5 years of the SIVAC initiative Vaccine ·Benítez Mejía, Kamel Senouci, Robin Biellik, Batmunkh Nyambat, 王常龄, 侯敏跃, Bradford D. Gessner, Aleena Kamal	2014	35
7	Measles resurgence in southern Africa: Challenges to measles elimination Vaccine ·Messeret Shibeshi, Balcha Masresha, Sheilagh Smit, Robin Biellik, Jennifer L. Nicholson, Alexandrina Damașcan, Douglas Isaias, O Walker, Reggis Katsande, James L. Goodson	2014	43
8	Researching routine immunization–do we know what we don’t know? Vaccine ·C. John Clements, Margaret Watkins, Ciro de Quadros, Robin Biellik, James L. Hadler, Deborah A. McFarland, Robert Steinglass, Elizabeth T. Luman, Karen Hennessey, Vance Dietz	2011	9
9	Impact of Measles Elimination Activities on Immunization Services and Health Systems: Findings From Six Countries The Journal of Infectious Diseases ·Piya Hanvoravongchai, Sandra Mounier‐Jack, Yixiang Nie, Dina Balabanova, Robin Biellik, En Riskinta Tumangger, Tracey Pérez Koehlmoos, Jutta Meuronen, Хельмут Вольман, Ha Nguyen, Pierre Ongolo‐Zogo, 信隆渡邉, Haribondhu Sarma, Maria Glória Teixeira, Jasim Uddin, Alya Dabbagh, Ulla Griffiths	2011	47
10	Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings Vaccine ·Robin Biellik, Carol Levin, Emmanuel Mugisha, D. Scott LaMontagne, Allison Bingham, Küster Breslau, Sanjay Gandhi	2009	36
11	Public-health impact of accelerated measles control in the WHO African Region 2000–03 The Lancet ·Mac W. Otten, Troy Bennet Petersen, Carmen Alicia Florián Navas, Balcha Masresha, Roland Martinꝉ, Jian Ouyang, Rudolf Eggers, Robin Biellik, Mark Grabowsky, Peter Strebel, O.V. Havryliyk, D Nshimirimana	2005	74
12	Impact of Alternative Approaches to Accelerated Measles Control: Experience in the African Region, 1996–2002 The Journal of Infectious Diseases ·Mac W. Otten, Jean‐Marie Okwo‐Bele, Troy Bennet Petersen, Robin Biellik, Nanao Kamata, D Nshimirimana	2003	24
13	Assessment of neonatal tetanus elimination in an African setting by lot quality assurance cluster sampling (LQA–CS) Epidemiology and Infection ·Benvon Cotter, Viviane Bremer, George Stroh, 李轩, Soniya Bhundere, 亮冯, 碧莹林, Robin Biellik, Maureen Birmingham	2003	6
14	Estrategias para reducir a un mínimo la transmisión nosocomial del sarampión Revista Panamericana de Salud Pública ·Robin Biellik, C. John Clements	1998	2
15	Poliomyelitis in Angola: Current Status and Implications for Poliovirus Eradication in Southern Africa The Journal of Infectious Diseases ·Héctor S. Izurieta, Robin Biellik, Olen M. Kew, 占彩雯, Hyun-San Shin, Roland W. Sutter	1997	6
16	Overview of Poliomyelitis in the African Region and Current Regional Plan of Action The Journal of Infectious Diseases ·Jin-Ju Pyo, Andrey A. Lobanov, Robin Biellik, Maureen Birmingham, Pierre Legrain, Oyewale Tomori, Song ChangJiang	1997	17
17	Deaths and injuries caused by land mines in Mozambique The Lancet ·Alberto Ascherio, Robin Biellik, Adrienne Epstein, Melis, Stephen Gloyd, Joseph D. Ayotte, Paul R. Epstein	1995	66
18	Poliomyelitis case confirmation: characteristics for use by national eradication programmes. Europe PMC (PubMed Central) ·Robin Biellik, Abraham (17..-1805?). Arrangeur, Jean-Marc Olivé, Ciro de Quadros	1992	7
19	Epidemiology of Poliomyelitis in the United States One Decade after the Last Reported Case of Indigenous Wild Virus-Associated Disease Clinical Infectious Diseases ·Peter Strebel, Roland W. Sutter, Stephen L. Cochi, Robin Biellik, Edward W. Brink, Olen M. Kew, Mark A. Pallansch, W. A. Orenstein, A. R. Hinman	1992	223
20	A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases. American Journal of Public Health ·Roland W. Sutter, Edward W. Brink, Stephen L. Cochi, Amran Ahmad, W. A. Orenstein, Robin Biellik, A. R. Hinman	1989	16

About Robin Biellik

Robin Biellik is a scholar working on Health, Modeling and Simulation, Infectious Diseases, Epidemiology and Endocrinology, having authored 49 papers that have together received 1.4k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (22 papers), Virology and Viral Diseases (17 papers), Viral Infections and Immunology Research (9 papers), Viral gastroenteritis research and epidemiology (7 papers), COVID-19 epidemiological studies (6 papers), Immune responses and vaccinations (4 papers), Influenza Virus Research Studies (3 papers) and Viral Infections and Outbreaks Research (3 papers). The work is most often cited by research in Health (606 citations), Microbiology (173 citations), Infectious Diseases (462 citations), Modeling and Simulation (104 citations) and Epidemiology (770 citations). Robin Biellik has collaborated with scholars based in United States, Zimbabwe and Switzerland. Frequent co-authors include Edward W. Brink, Peter Strebel, Roland W. Sutter, A. R. Hinman, Stephen L. Cochi, W. A. Orenstein, Olen M. Kew, Mark A. Pallansch, Élisabeth Botelho-Nevers and Philippe Brouqui. Their work appears in journals such as The Journal of Infectious Diseases, Vaccine, The Lancet, Clinical Infectious Diseases and Disasters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact